Clinical Trial Update: STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis) [NA]

View source ↗

Summary

The STAR trial evaluating transcatheter aortic valve replacement in patients with symptomatic severe native aortic stenosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: MiRus | Conditions: Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis | NA | Status: RECRUITING